Clinical Trial Update: Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether administering a gonadotropin-releasing hormone agonist during chemotherapy reduces ovarian failure in women with early-stage ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED